This study investigates the effects of a standard two-drug combination treatment compared to an experimental three-drug combination. The purpose is to understand how these treatments affect patients, including any potential benefits or side effects.
Participants in the study will receive either the standard two-drug treatment or the experimental three-drug treatment. The study will monitor the effects of these treatments to compare their outcomes.
- Who can participate: Adults aged 18-65 with a diagnosis relevant to the study focus, who are not currently receiving other investigational treatments, may be eligible to participate.
- Study details: Participants will receive either the standard two-drug combination or the investigational three-drug combination. The effects will be monitored and compared. If applicable, a placebo will be used to assess treatment efficacy, defined as a substance with no therapeutic effect used as a control in testing new drugs.
